Epigenetics and Psychiatric Disease - 1st Edition - ISBN: 9780128135655, 9780128135662

Epigenetics and Psychiatric Disease, Volume 157

1st Edition

Serial Volume Editors: Dennis Grayson
eBook ISBN: 9780128135662
Hardcover ISBN: 9780128135655
Imprint: Academic Press
Published Date: 22nd June 2018
Page Count: 450
Sales tax will be calculated at check-out Price includes VAT/GST
122.00
103.70
171.00
145.35
119.00
101.15
239.04
203.18
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Epigenetic Landscapes of the Adversity-exposed Brain
Tania L. Roth
2. Chromosomal Conformations and Epigenomic Regulation in Schizophrenia
Schahram Akbarian
3. Progress in Epigenetics of Depression
Eric J. Nestler
4. Epigenetics of circadian rhythms in imprinted neurodevelopmental disorders
Janine M. LaSalle
5. DNA methylation mediating substance abuse; mechanisms and therapeutic opportunities
Moshe Szyf
6. DNA Methylation in Animals Model of Psychosis
Alessandro Guidotti and Dennis R. Grayson
7. Epigenetics of early life stress
Chris Murgatroyd
8. Epigenetic Drugs for Mood Disorders
Jacob Peedicayil
9. Behind Epigenetic Alterations in Psychiatric Diseases
Hamid M. Abdolmaleky
10. DNA methylation and its possible role in psychiatric disorders
Chunyu Liu
11. Neuroepigenetics of suicide brain
ogesh Dwivedi
12. Epigenetic Mechanisms of Traumatic Brain Injuries
Amul Sakharkar
13. Non-protein-coding RNAs in Fetal Alcohol Spectrum Disorders
Rajesh C. Miranda
14. Targeting histone-modifications as a therapeutic approach to treat psychosis
Andre Fischer
15. The epigenetics of early life adversity: current limitations and possible solutions
Gustavo Turecki


Description

Epigenetics and Psychiatric Disease, Volume 157, the latest volume in the Progress in Molecular Biology and Translational Science series, includes recent developments on a variety of topics, including the Epigenetic landscapes of the adversity-exposed brain, Chromosomal conformations and epigenomic regulation in schizophrenia, Progress in the epigenetics of depression, the epigenetics of circadian rhythms in imprinted neurodevelopmental disorders, DNA methylation mediating substance abuse, mechanisms and therapeutic opportunities, DNA methylation in animals model of psychosis, Epigenetics of early life stress, Epigenetic drugs for mood disorders, and more.

Key Features

  • Accessible to students and researchers alike, with content that appeals to a variety of readers
  • Written by leading authorities in their respective fields of molecular biology

Readership

Students, researchers, microbiologists, molecular biologists


Details

No. of pages:
450
Language:
English
Copyright:
© Academic Press 2018
Published:
Imprint:
Academic Press
eBook ISBN:
9780128135662
Hardcover ISBN:
9780128135655

Reviews

Praise for the Series:
"Maintains the tradition and set-up of the previous volumes and certainly provides up-to-date data on varied aspects of cytology... a valuable acquisition to any library." --The Nucleus

Ratings and Reviews


About the Serial Volume Editors

Dennis Grayson Serial Volume Editor

Dr. Grayson has been interested in mechanisms associated with gene expression for over 20 years. He joined the laboratory of Dr. James E. Darnell, Jr. at the Rockefeller University on 1984 to study cell-type specific transcription factors. This led to the identification of HNF3A as a hepatocyte nuclear factor important for activating the expression of multiple genes in hepatocytes. In 1988, Dr. Grayson joined the Fidia-Georgetown Institute for the Neurosciences and with the support of Dr. Erminio Costa, initiated a program in studying gene expression in neurons. From 1994-1998, he moved to the Allegheny University of the Health Sciences in Pittsburgh and developed a program in molecular psychiatry. He continued his interests in psychiatry and joined the Psychiatric Institute in 1998. This represented a unique opportunity to join his long time collaborators, Drs. Costa and Guidotti to pursue molecular underpinnings of schizophrenia. Dr. Grayson has received NRSA post-doctoral support, R01 and K04 funding from the NIH over the years. He has published over 100 papers in peer-reviewed journals and actively reviews NIH grants and post-doctoral fellowships. In addition, Dr. Grayson has been invited to speak at numerous national and international meetings.

Affiliations and Expertise

Professor of Molecular Neuroscience, University of Illinois at Chicago, IL, USA